These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070 [TBL] [Abstract][Full Text] [Related]
45. [Hyperhomocysteinemia: a new marker of vascular risk: affected vascular areas, its role in the pathogenesis of arteriosclerosis and thrombosis and treatment]. Córdoba Porras A; Blanco Vaca F; González Sastre F Med Clin (Barc); 1997 Nov; 109(18):715-25. PubMed ID: 9499150 [No Abstract] [Full Text] [Related]
46. Anaesthetic management of a young patient with homocystinuria. Asghar A; Ali FM J Coll Physicians Surg Pak; 2012 Nov; 22(11):720-2. PubMed ID: 23146854 [TBL] [Abstract][Full Text] [Related]
48. Hyperhomocysteinaemia: a risk factor for extracranial carotid artery atherosclerosis. Clarke R; Fitzgerald D; O'Brien C; O'Farrell C; Roche G; Parker RA; Graham I Ir J Med Sci; 1992 Mar; 161(3):61-5. PubMed ID: 1517057 [TBL] [Abstract][Full Text] [Related]
49. Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria? Sellos-Moura M; Glavin F; Lapidus D; Evans KA; Palmer L; Irwin DE Mol Genet Metab; 2020 May; 130(1):36-40. PubMed ID: 32057642 [TBL] [Abstract][Full Text] [Related]
50. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Yap S; Boers GH; Wilcken B; Wilcken DE; Brenton DP; Lee PJ; Walter JH; Howard PM; Naughten ER Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2080-5. PubMed ID: 11742888 [TBL] [Abstract][Full Text] [Related]
51. Homocysteine as a risk factor for arteriosclerosis. Kuritzky L Hosp Pract (1995); 1996 Mar; 31(3):37, 41. PubMed ID: 8596007 [No Abstract] [Full Text] [Related]
52. [Juvenile cerebral vascular disease and homocystinuria]. Noya M; Lema M; Castillo C; Castro A; Dapena D; Arias M; Ansede A Rev Clin Esp; 1984 Oct; 175(1):51-2. PubMed ID: 6522717 [No Abstract] [Full Text] [Related]
53. Quasi-moyamoya disease and heterozygosity for homocystinuria in a five-year-old girl. van Diemen-Steenvoorde R; van Nieuwenhuizen O; de Klerk JB; Duran M Neuropediatrics; 1990 May; 21(2):110-2. PubMed ID: 2359484 [TBL] [Abstract][Full Text] [Related]
54. [Vascular and ocular complications in a child with homocystinuria]. Leuenberger S; Faulborn J; Sturrock G; Gloor B; Rehorek R; Baumgartner R Schweiz Med Wochenschr; 1984 Jun; 114(22):793-8. PubMed ID: 6610936 [TBL] [Abstract][Full Text] [Related]
55. [Homocystinuria]. Li ZH Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):238-40. PubMed ID: 6439526 [No Abstract] [Full Text] [Related]
57. Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment. Boers G Eur J Pediatr; 1998 Apr; 157 Suppl 2():S127-30. PubMed ID: 9587040 [TBL] [Abstract][Full Text] [Related]
58. Treatment of extrapyramidal symptoms in a patient with homozygous homocystinuria. Burlina AP; Edini C; Burlina AB J Inherit Metab Dis; 2002 May; 25(2):135-6. PubMed ID: 12118530 [No Abstract] [Full Text] [Related]
59. Ultrasonographic detection of arterial disease in treated homocystinuria. Rubba P; Faccenda F; Strisciuglio P; Andria G N Engl J Med; 1989 Dec; 321(25):1759-60. PubMed ID: 2687690 [No Abstract] [Full Text] [Related]
60. Homocysteine--what does it mean and have we been led astray? Young IS; Woodside JV Int J Clin Pract; 2010 Feb; 64(3):281-4. PubMed ID: 20456165 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]